|

Lithium Clinical Trials

4 actively recruiting trials

Also known as: ATC code: N05AN01, Litarex, ATC; N05AN01, Lithionit, Lithium sulphate

Pipeline

Phase 2: 1Phase 3: 2Phase 4: 1

Top Sponsors

  • Dr. Inge Winter2
  • Region Stockholm1
  • Aalborg University Hospital1

Indications

  • Depression3
  • Bipolar Depression2
  • Schizophrenia and Related Disorders1
  • Depression Bipolar1
  • Major Depressive Disorder1

Other4 trials

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Phase 3
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Phase 2
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
Phase 4
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.